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E D I T O R I A L
Dear Reader, In this issue, we feature excellent new papers by John Robertson and Alan Wertheimer. We are also pleased to launch our student development section, which will be a part of each forthcoming Journal of Law and the Biosciences (JLB) issue. These student developments are brief summaries of and commentary on recent legislation, regulation, and case law relevant to the biosciences that are written by students at each of the sponsoring schools.
Special to this JLB issue is the publication of a selection of public commentaries (with new introductory material for JLB), which were originally submitted to the Presidential Commission for the Study of Bioethical Issues concerning the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative. On April 2, 2013, President Barack Obama announced the BRAIN Initiative as part of a new Presidential focus aimed at revolutionizing our understanding of the human brain. Recognizing that the research may hold great potential to treat, prevent, and cure brain diseases and disorders, the Initiative aims to accelerate the development and application of innovative technologies. We offer this selection here to foster a broader public dialogue.
Given that an ambitious and revolutionary initiative presents significant ethical and legal concerns, the BRAIN Initiative Advisory Committee to the Director recommended serious and sustained consideration of the potential ethical implications of neuroscience research. They specifically highlighted possible concerns with neural enhancement, data privacy, and appropriate use of brain data in law, education, and business.
President Obama tasked the Presidential Commission for the Study of Bioethical Issues with exploring these and other potential ethical and legal issues. In his request, President Obama emphasized both the importance of ensuring ethical research standards and the need to consider questions concerning appropriate and justified applications of neuroscience technologies within society.
The Commission released a 'Request for Comments on the Ethical Considerations of Neuroscience Research and the Application of Neuroscience Findings' to ensure that its assessment reflects the values and concerns of all neuroscience stakeholders, including experts, potential medical beneficiaries, and the general public. In this request, the C The Author 2014. Published by Oxford University Press on behalf of Duke University School of Law, Harvard Law School, Oxford University Press, and Stanford Law School. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons. org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com Commission encouraged individuals, groups, and organizations to submit comments for consideration in its deliberations.
The Commission has since released its first set of recommendations in response to President Obama's request. These preliminary recommendations focus primarily on ethical research conduct and the importance of ethics in neuroscience research. The Commission's second set of recommendations, expected later this year, will address ethical issues that may be raised by the application of neuroscience findings.
This issue of JLB seeks to increase awareness of the issues and challenges presented to the Commission in order to inspire further discussion on the rapid advancements of neuroscience technologies. As the first fully open access peer-reviewed legal journal focused on the advances at the intersection of law and the biosciences, JLB is an ideal place to expand this conversation. We hope an increasing number of lawyers, ethicists, scientists, and members of the public will join and help diversify that conversation.
In the coming pages, prominent commentators share their thoughts on the implications of this research for the law and ethics of human cognition, behavior, free will, and mental health. Commentators additionally describe the practical challenges of transforming traditional legal and health practices to coincide with novel insights of the human brain.
We at JLB welcome you to submit original submissions or responses to the commentaries or to any articles we publish. In upcoming issues, we hope to continue to foster the dialogue both on neuroscience technologies and on other issues related to law and the biosciences.
